Journal
JOURNAL OF NEUROSCIENCE
Volume 28, Issue 15, Pages 3947-3957Publisher
SOC NEUROSCIENCE
DOI: 10.1523/JNEUROSCI.5667-07.2008
Keywords
histone monoubiquitylation; huntingtin; Bmi-1; histone methylation; transcription; histone code
Categories
Funding
- NINDS NIH HHS [P01 NS045242-030004, P01 NS045242, NS38106, R01 NS038106-06, NS45242, R01 NS038106] Funding Source: Medline
Ask authors/readers for more resources
Although transcriptional dysregulation is a critical pathogenic mechanism in Huntington's disease (HD), it is still not known how mutant huntingtin causes it. Here we show that alteration of histone monoubiquitylation is a key mechanism. Disrupted interaction of huntingtin with Bmi-1, a component of the hPRC1L E3 ubiquitin ligase complex, increases monoubiquityl histone H2A (uH2A) levels in a cell culture model of HD. Genes with expression that is repressed in transgenic R6/2 mouse brain have increased uH2A and decreased uH2B at their promoters, whereas actively transcribed genes show the opposite pattern. Reduction in uH2A reverses transcriptional repression and inhibits methylation of histone H3 at lysine 9 in cell culture. In contrast, reduction in uH2B induces transcriptional repression and inhibits methylation of histone H3 at lysine 4. This is the first report to demonstrate hPRC1L as a huntingtin-interacting histone modifying complex and a crucial role for histone monoubiquitylation in mammalian brain gene expression, which broadens our understanding of histone code. These findings also provide a rationale for targeting histone monoubiquitylation for therapy in HD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available